Difference between revisions of "Cabazitaxel (Jevtana)"

From HemOnc.org - A Hematology Oncology Wiki
Jump to navigation Jump to search
(delete regimens section)
m (also known as, patient information)
Line 1: Line 1:
 +
Also known as XRP6258, TXD258, or RPR116258A.
 +
 
==General information==
 
==General information==
 
Class/mechanism: Taxane, promotes assembly of microtubules, stablizes microtubules, preventing depolymerization, inhibiting interphase/mitosis processes.<ref name="insert">[http://products.sanofi.us/jevtana/jevtana.pdf Cabazitaxel (Jevtana) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/cabazitaxel.pdf Cabazitaxel (Jevtana) package insert (locally hosted backup)]</ref>
 
Class/mechanism: Taxane, promotes assembly of microtubules, stablizes microtubules, preventing depolymerization, inhibiting interphase/mitosis processes.<ref name="insert">[http://products.sanofi.us/jevtana/jevtana.pdf Cabazitaxel (Jevtana) package insert]</ref><ref>[http://hemonc.org/docs/packageinsert/cabazitaxel.pdf Cabazitaxel (Jevtana) package insert (locally hosted backup)]</ref>
Line 4: Line 6:
 
<br>Extravasation: no information
 
<br>Extravasation: no information
  
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the package insert<ref name="insert"></ref>.  
+
For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer.  Instead, for the most current information, please refer to your preferred pharmacopeias such as [http://www.thomsonhc.com/home/dispatch Micromedex], [http://online.lexi.com/ Lexicomp], [http://www.utdol.com/online/content/search.do UpToDate (courtesy of Lexicomp)], or the prescribing information<ref name="insert"></ref>.  
  
 
==Patient drug information==
 
==Patient drug information==
 +
*[http://products.sanofi.us/jevtana/jevtana.pdf#page=5 Cabazitaxel (Jevtana) package insert PDF pages 5-6]<ref name="insert"></ref>
 
*[http://www.uptodate.com/contents/cabazitaxel-patient-drug-information Cabazitaxel (Jevtana) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/cabazitaxel-patient-drug-information Cabazitaxel (Jevtana) patient drug information (UpToDate)]</ref>
 
*[http://www.uptodate.com/contents/cabazitaxel-patient-drug-information Cabazitaxel (Jevtana) patient drug information (UpToDate)]<ref>[http://www.uptodate.com/contents/cabazitaxel-patient-drug-information Cabazitaxel (Jevtana) patient drug information (UpToDate)]</ref>
  
 
==References==
 
==References==
 
<references/>
 
<references/>

Revision as of 06:53, 21 March 2012

Also known as XRP6258, TXD258, or RPR116258A.

General information

Class/mechanism: Taxane, promotes assembly of microtubules, stablizes microtubules, preventing depolymerization, inhibiting interphase/mitosis processes.[1][2]
Route: IV
Extravasation: no information

For conciseness and simplicity, HemOnc.org currently will focus on treatment regimens and not list information such as: renal/hepatic dose adjustments, metabolism (including CYP450), excretion, monitoring parameters (although this will be considered for checklists), or manufacturer. Instead, for the most current information, please refer to your preferred pharmacopeias such as Micromedex, Lexicomp, UpToDate (courtesy of Lexicomp), or the prescribing information[1].

Patient drug information

References